Supported by unrestricted educational grants from Alcon, Carl Zeiss Meditec, Inc., Glaukos, and Johnson & Johnson Vision
Upon completion of this activity, the participant should be able to:
Identify methods to improve surgical, and ocular surface and corneal disease outcomes through comanagement of cataract, refractive, and corneal patients
Describe the impact that OSD has on contact lens wear and drop out as well as overall cataract and refractive surgery outcomes
Compare and contrast traditional and new and emerging diagnostic tests in classifying ocular surface disease severity and differentiating MGD
Increase confidence in making therapeutic decisions for OSD patients based on disease classification, including acute exacerbations of dry eye disease, chronic dry eye, and MGD
Explore approaches to ocular surface toxicity when OSD patients are treated for comorbid conditions
Douglas K. Devries, OD, Moderator
Co-Founder and Managing Partner
Eye Care Associates of Nevada
Sparks, Nevada
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Douglas K. Devries, OD, and/or spouse had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant and Speakers Bureau: Alcon, Bausch+ Health, Bio Tissue, Dompe, Eyevance, Johnson & Johnson Vision, Lumeris, Novartis, OcuSoft, Sun, and TearLab, Share/Stockholder: RPS.
EDITORIAL DISCLOSURES
Erin K. Fletcher, MIT, director of compliance and education; Evolve; and Kate Fehlhaber, PhD, writer, have no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Alcon, Carl Zeiss Meditec, Glaukos, or Johnson & Johnson Vision.
